ABEO Projected Dividend Yield
Abeona Therapeutics Inc ( NASDAQ : ABEO )Abeona Therapeutics is a clinical-stage biopharmaceutical company developing cell and gene therapies for life-threatening diseases. Co.'s primary clinical program is EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosaan autologous, engineered cell therapy that is in development for recessive dystrophic epidermolysis bullosa. Co.'s development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat the unmet medical need ophthalmic diseases using the AIM™ capsid platform that Co. has licensed from University of North Carolina at Chapel Hill, and internal AAV vector research programs. 20 YEAR PERFORMANCE RESULTS |
ABEO Dividend History Detail ABEO Dividend News ABEO Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |